What it sells
Our tests help eradicate cancer by telling doctors whether they got…
Business model breakdown
Workflow: what inputs become what output?
Labs replace multiple interpretive programs with one MICA Software and use drop-in MICA test kits instead of PCR RNA isolation.
Economics: what it saves and how it charges
Sells MICA software and test kits to clinical labs, and develops RNA residual disease diagnostics.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2018 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.